Does ADALIMUMAB Cause Therapeutic response shortened? 2,597 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,597 reports of Therapeutic response shortened have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.5% of all adverse event reports for ADALIMUMAB.
2,597
Reports of Therapeutic response shortened with ADALIMUMAB
0.5%
of all ADALIMUMAB reports
4
Deaths
468
Hospitalizations
How Dangerous Is Therapeutic response shortened From ADALIMUMAB?
Of the 2,597 reports, 4 (0.2%) resulted in death, 468 (18.0%) required hospitalization, and 8 (0.3%) were considered life-threatening.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 2,597 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
NALTREXONE (658)
Which ADALIMUMAB Alternatives Have Lower Therapeutic response shortened Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB